Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise ... Get the latest Intellia Therapeutics Inc. (NTLA) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis. In depth view into NTLA (Intellia Therapeutics) stock including the latest price, news, dividend history, earnings information and …2 days ago · On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ:NTLA) and slightly increased the price target to $73 from $72. The adjustment …4 days ago · Intellia Therapeutics, Inc. (NTLA) Stock Price, Quote & News - Stock Analysis 29.61 +1.38 (4.89%) At close: Feb 12, 2024, 4:00 PM 29.80 +0.19 (0.64%) Pre-market: …The European Commission bestows orphan drug designation to Intellia's (NTLA) in vivo CRISPR-based investigational therapy, NTLA-2002, for treating hereditary angioedema. Stock rises.While it's true that there are a few positive catalysts coming for Intellia's stock, it's difficult to see how the share price could possibly rise by as much as Wall Street currently calculates ...Jan 21, 2024 · The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Intellia Therapeutics wasn't one of them. The 10 stocks that ... 3 days ago · View Intellia Therapeutics, Inc NTLA investment & stock information. Get the latest Intellia Therapeutics, Inc NTLA detailed stock quotes, stock data, Real-Time ECN, …Intellia Therapeutics stock price forecast* for tomorrow, and next weeks based on the last 30 days [60% OFF VIP SALE] Portfolio is UP +117% in 2023 - Try Now Risk-Free - Money-back guarantee! NTLA forecast for the upcoming days Date Price Min Price Max Price; 2024-02-26: Price: 26.742: Min: 25.357: Max: ...Analysts Say Intellia Therapeutics Stock Could Rise 157% This Year, but Will It Happen? - Yahoo Finance ... Intellia Therapeutics price target lowered to $24 from $38 at Baird. Baird lowered the firm’s price target on Intellia Therapeutics (NTLA) to $24 from $38 and keeps a Neutral rating on the shares. The firm said they are negative...On Friday, Canaccord Genuity (TSX: CF) maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Feb 17, 2024 · Wall Street analysts are quite bullish about Intellia Therapeutics (NASDAQ: NTLA) stock. On average, they're estimating that it'll rise by around 157% within the next …Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis. In depth view into NTLA (Intellia Therapeutics) stock including the latest price, news, dividend history, earnings information and …Intellia Therapeutics, Inc. Common Stock (NTLA) Real-time Stock Quotes ... You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com.Stock analysis for Intellia Therapeutics Inc (NTLA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...The latest closing stock price for Intellia Therapeutics as of January 05, 2024 is 28.63. The all-time high Intellia Therapeutics stock closing price was 176.78 on September 03, 2021. The Intellia Therapeutics 52-week high stock price is 47.48, which is 65.8% above the current share price. The Intellia Therapeutics 52-week low stock price is 22 ...Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...Complete Intellia Therapeutics Inc. stock information by Barron's. View real-time NTLA stock price and news, along with industry-best analysis.Feb 12, 2024 · Get Intellia Therapeutics Inc (NTLA.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Nov 10, 2023 · General and administrative expenses surged 32.8% year over year to $29.4 million due to an increase in stock-based compensation of $5.3 million. ... Intellia Therapeutics, Inc. Price and Consensus. Current Price. $26.10. Price as of February 23, 2024, 4:00 p.m. ET ... Does Intellia Therapeutics have what it takes to make a comeback, or is it too late to get in on the stock? Intellia ...RBC Cuts Price Target on Intellia Therapeutics to $70 From $80, Keeps Outperform, Speculative Risk Nov. 10: MT ... Stock Intellia Therapeutics, Inc. - Nasdaq . News Intellia Therapeutics, Inc. Transcript : Intellia Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 05 ...02/22/2024. Intellia Therapeutics stock price stood at $27.18. According to the latest long-term forecast, Intellia Therapeutics price will hit $30 by the end of 2024 and then $40 by the middle of 2025. Intellia Therapeutics will rise to $45 within the year of 2026, $55 in 2027, $65 in 2028, $75 in 2029, $85 in 2030, $90 in 2032, $95 in 2033 and $100 …Get Intellia Therapeutics Inc (NTLA.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments In other words, there will be updates along the way and the share price will go up or down depending on the updates. In other words, one doesn't have to wait for a long time for price movement ...Current Price. $26.10. ... It's easy to imagine progress in clinical trials or eventually a product approval driving investors to buy the stock and bringing Intellia's market value in line with ...Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...The above is based on 19 Wall Street analysts offering 12-month price targets for Intellia in the last 3 months. The average price target is $173.11 with a high forecast of $238.00 and a low ...You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...r/IntelliaTherapeutics: Unofficial - Intellia Therapeutics Stock Message Board on Reddit. CRISPR technology and stock prices discussion.Intellia Therapeutics Stock Earnings. The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained. Intellia Therapeutics ( NTLA) reported Q3 2023 earnings per share (EPS) of -$1.38, beating estimates of -$1.50 by 7.99%. In the same quarter last year, Intellia Therapeutics 's earnings per share (EPS) was -$1.49.Feb 17, 2024 · Wall Street analysts are quite bullish about Intellia Therapeutics (NASDAQ: NTLA) stock. On average, they're estimating that it'll rise by around 157% within the next …Intellia Therapeutics Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in Patients with Hereditary Angioedema in the New England Journal of Medicine. Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing.Intellia Therapeutics Inc stock price live 27.74, this page displays NASDAQ NTLA stock exchange data. View the NTLA premarket stock price ahead of the market session or assess the after hours quote.Intellia Therapeutics, Inc. Common Stock (NTLA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. CRISPR specialist Intellia Therapeutics on Thursday said it will lay off about 15% of its workforce as it pauses some early-stage research.. The cuts come a little over three months after Intellia, one of the first companies founded to turn the gene editing technology into medicines, received a green light from U.S. regulators to begin a late …The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a significant 31% fall in a month while it is down 34% over the ...The Intellia Therapeutics Inc (NTLA) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $35.09, representing a +29.09% increase from the current price of $27.18. The highest analyst price target is $39.38, and the lowest is $30.80. Intellia Therapeutics, Inc. Common Stock (NTLA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Intellia Therapeutics Inc stock price (NTLA) NASDAQ: NTLA. ... Intellia Therapeutics Inc stock performance at a glance. Check Intellia Therapeutics Inc’s past financial performance, like revenue or net income, plus the top …If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...The consensus price target hints at an 185.5% upside potential for Intellia Therapeutics, Inc. (NTLA). While empirical research shows that this sought-after metric is hardly effective, an upward ...See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ... NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow ... 3 days ago · 19 brokerages have issued 1-year price objectives for Intellia Therapeutics' stock. Their NTLA share price targets range from $29.00 to $136.00. On average, they anticipate the company's share price to reach $74.11 in the next year. This suggests a possible upside of 167.2% from the stock's current price. 28 Oct 2023 ... So (depending on pricing) Intellia may find it tough both to get insurers to cover its medicine, and to find patients willing to pay if they're ...The latest closing stock price for Intellia Therapeutics as of January 05, 2024 is 28.63. The all-time high Intellia Therapeutics stock closing price was 176.78 on September 03, 2021. The Intellia Therapeutics 52-week high stock price is 47.48, which is 65.8% above the current share price. The Intellia Therapeutics 52-week low stock price is 22 ... Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary.Intellia Therapeutics Inc stock price (NTLA) NASDAQ: NTLA. ... Intellia Therapeutics Inc stock performance at a glance. Check Intellia Therapeutics Inc’s past financial performance, like revenue or net income, plus the top …3 days ago · On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ:) and slightly increased the price target to $73 from $72. The adjustment follows Intellia’s fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement. Is Intellia Therapeutics stock public? Yes, Intellia Therapeutics is a publicly traded company. · What is the Intellia Therapeutics stock quote today? The ...Factors That Drove Intellia Therapeutics (NTLA) Stock Price Change Between 2021-End And Now: ; Factors Of Stock Price Change ; Price To Sales Ratio (P/S), 264.4 ...Feb 14, 2024 · View Intellia Therapeutics, Inc. NTLA stock quote prices, financial information, real-time forecasts, and company news from CNN.Intellia Therapeutics, Inc. Common Stock (NTLA) Pre-Market Stock Quotes ... You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com.Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary. Intellia Therapeutics, Inc. Common Stock (NTLA) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. NTLA - Intellia Therapeutics, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGM)When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks...Research Intellia Therapeutics' (Nasdaq:NTLA) stock key valuation metrics while comparing it with its industry peers & market side by side. ... The above table shows the analyst NTLA forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current ...On Friday, Canaccord Genuity (TSX: CF) maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Intellia Therapeutics stock price forecast* for tomorrow, and next weeks based on the last 30 days [60% OFF VIP SALE] Portfolio is UP +117% in 2023 - Try Now Risk-Free - Money-back guarantee! NTLA forecast for the upcoming days Date Price Min Price Max Price; 2024-02-26: Price: 26.742: Min: 25.357: Max: ...In other words, there will be updates along the way and the share price will go up or down depending on the updates. In other words, one doesn't have to wait for a long time for price movement ...On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.4 days ago · Intellia Therapeutics, Inc. (NTLA) Stock Price | Stock Quote Nasdaq - MarketScreener INTELLIA THERAPEUTICS, INC. PDF Report Equities NTLA …Feb 16, 2024 · NTLA, Intellia Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines The Intellia Therapeutics stock forecast for tomorrow is $ 27.15, which would represent a -2.12% loss compared to the current price. In the next week, the price of NTLA is expected to decrease by -2.51% and hit $ 27.04.. As far as the long-term Intellia Therapeutics stock forecast is concerned, here’s what our predictions are currently …Intellia Therapeutics Inc stock price live 27.74, this page displays NASDAQ NTLA stock exchange data. View the NTLA premarket stock price ahead of the market session or assess the after hours quote.On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.1 Jan 2024 ... Key Insights · The projected fair value for Intellia Therapeutics is US$40.78 based on 2 Stage Free Cash Flow to Equity · Current share price of ....Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...Intellia Therapeutics stock prediction for May 2025. The forecast for beginning 52.37 dollars. Maximum price 58.68, minimum 49.98. Averaged Intellia Therapeutics stock price for the month 53.84. At the end 54.33 dollars, change for May 3.7%. Intellia Therapeutics stock price forecast for June 2025.Intellia Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NTLA stock price. 4 days ago · Intellia Therapeutics, Inc. (NTLA) Stock Price | Stock Quote Nasdaq - MarketScreener INTELLIA THERAPEUTICS, INC. PDF Report Equities NTLA …Intellia Therapeutics Stock Forecast, NTLA stock price prediction. Price target in 14 days: 30.739 USD. The best long-term & short-term Intellia ...Intellia Therapeutics (NTLA) Stock Key Data. Summary Additional Data Analysts Historical Quotes. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months.RBC Cuts Price Target on Intellia Therapeutics to $70 From $80, Keeps Outperform, Speculative Risk Nov. 10: MT ... Stock Intellia Therapeutics, Inc. - Nasdaq . News Intellia Therapeutics, Inc. Transcript : Intellia Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 05 ...See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ... NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow ...
Intellia Therapeutics Inc’s Stock Price Change Based on Its Q3 Earnings Report. The stock market is considered to always be “forward-looking,” which means share prices are established based on the expectations that prospective investors have for the future earnings power of the company. In fact, expectations play a key role in determining .... Last knights
MT. Wedbush Lowers Intellia Therapeutics' Price Target to $29 From $45, Maintains Neutral Rating. Nov. 10. MT. Intellia Therapeutics Shares Fall After Net Loss Narrows, but Revenue Falls in Q3. Nov. 09. MT. Transcript : Intellia Therapeutics, Inc., Q3 2023 Earnings Call, Nov 09, 2023.Get Intellia Therapeutics Inc (NTLA.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsIntellia’s stock jumps as CRISPR therapy moves into Phase 2 clinical trial MarketWatch. Friday, January 06, 2023. 07:49 AM ET. Intellia Therapeutics stock price target cut to $131 from $173 at Stifel Nicolaus MarketWatch. Tuesday, October 11, 2022. 09:41 AM ET. Intellia Therapeutics started at overweight with $84 stock price target at …Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing. Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may...4 days ago · Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. The …On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.On average, Wall Street analysts predict. that Intellia Therapeutics's share price could reach $77.86 by Nov 13, 2024. The average Intellia Therapeutics stock price prediction forecasts a potential upside of 162.94% from the current NTLA share price of $29.61 .1 Jan 2024 ... Key Insights · The projected fair value for Intellia Therapeutics is US$40.78 based on 2 Stage Free Cash Flow to Equity · Current share price of ....Intellia's (NTLA) in-vivo CRISPR-based gene-edited therapy candidate NTLA-2001 holds potential. ... Free Stock Analysis Report. Intellia Therapeutics, Inc. (NTLA) : Free Stock Analysis Report ...RBC Cuts Price Target on Intellia Therapeutics to $70 From $80, Keeps Outperform, Speculative Risk Nov. 10: MT Wedbush Lowers Intellia Therapeutics' Price Target to $29 From $45, Maintains Neutral Rating Nov. 10: MT Intellia Therapeutics Shares Fall After Net Loss Narrows, but Revenue Falls in Q3 ... Stock Intellia Therapeutics, Inc. ….